During the past decade, Hemophilia Center of Western New York conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hemophilia Center of Western New York" #1 sponsor was "Bayer" with 1 trials, followed by "Baylor College of Medicine" with 1 trials sponsored, "CSL Behring" with 1 trials sponsored, "Freeline Therapeutics" with 1 trials sponsored and "Genzyme, a Sanofi Company" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hemophilia Center of Western New York" #1 collaborator was "Shire" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hemophilia Center of Western New York" are "Hemophilia B" (2 trials), "Blood Coagulation Disorder" (1 trials), "Blood Coagulation Disorders, Inherited" (1 trials), "Cerebroside Lipidosis Syndrome" (1 trials) and "Gaucher Disease, Non-Neuronopathic Form" (1 trials). Many other conditions were trialed in "Hemophilia Center of Western New York" in a lesser frequency.

Most popular intervention types in "Hemophilia Center of Western New York" are "Biological" (2 trials), "Drug" (1 trials), "Genetic" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "AAV5-hFIXco-Padua" (1 trials), "Cerezyme" (1 trials), "Complete Bleeding Symptom ISTH Bleeding Assessment Tool" (1 trials), "Factor IX (FIX)" (1 trials) and "Genetic Analysis" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hemophilia Center of Western New York" are 3 trials for "Male" genders, 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hemophilia Center of Western New York". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hemophilia Center of Western New York, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hemophilia Center of Western New York, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".